Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cidara Therapeutics, Inc. | 50,000 | reported | 31 Mar 2017 | tx 2+100,000 |
| Trius Therapeutics Inc | 0 | reported | 11 Sept 2013 | tx 16+205,000−366,051 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2017 | GRANT_AWARD | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 16 Mar 2016 | GRANT_AWARD | Cidara Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 96,400 | — | |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 90,000 | 7.37 USD | deriv |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 75,000 | 8.70 USD | deriv |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 16,569 | 12.21 USD | deriv |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 6,395 | 12.21 USD | deriv |
| 11 Sept 2013 | OTHER | Trius Therapeutics Inc | 40,000 | 10.00 USD | deriv |
| 01 Jul 2013 | SALE | Trius Therapeutics Inc | 2,000 | 8.14 USD | |
| 04 Jun 2013 | SALE | Trius Therapeutics Inc | 2,000 | 7.90 USD | |
| 24 May 2013 | SALE | Trius Therapeutics Inc | 12,000 | 7.93 USD | |
| 14 May 2013 | SALE | Trius Therapeutics Inc | 12,000 | 7.85 USD | |
| 07 Mar 2013 | GRANT_AWARD | Trius Therapeutics Inc | 90,000 | 0.00 USD | deriv |
| 08 Mar 2012 | GRANT_AWARD | Trius Therapeutics Inc | 75,000 | 0.00 USD | deriv |
| 17 Nov 2011 | SALE | Trius Therapeutics Inc | 1,687 | 7.85 USD | |
| 03 Nov 2010 | GRANT_AWARD | Trius Therapeutics Inc | 30,000 | 0.00 USD | deriv |
| 03 Nov 2010 | GRANT_AWARD | Trius Therapeutics Inc | 10,000 | 0.00 USD | deriv |